The highest prevalence of TF expression (≥75% TF‐positive tumor biopsies, with either membranous or cytoplasmic TF expression) was found in glioblastoma, pancreatic cancer, cervical cancer, colon cancer, NSCLC, and HNSCC. Here, TF is linked to non-small cell lung carcinoma.